ARTICLE | Company News
Amgen, Servier deal
September 5, 2016 7:00 AM UTC
Servier exercised an option from Amgen to license commercialization rights to omecamtiv mecarbil for chronic heart failure in Europe and the Commonwealth of Independent States (CIS). Amgen will recei...